Quanterix Corp Files 8-K on Security Holder Votes & Financials
Ticker: QTRX · Form: 8-K · Filed: Oct 2, 2025 · CIK: 1503274
| Field | Detail |
|---|---|
| Company | Quanterix Corp (QTRX) |
| Form Type | 8-K |
| Filed Date | Oct 2, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: QTRX
TL;DR
Quanterix filed an 8-K on 9/29/25 covering shareholder votes and financials. Standard update.
AI Summary
Quanterix Corporation filed an 8-K on October 2, 2025, reporting on matters submitted to a vote of security holders and financial statements as of September 29, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). Quanterix is a manufacturer of laboratory analytical instruments.
Why It Matters
This 8-K filing provides essential updates on Quanterix's corporate governance and financial reporting, which are crucial for investors to assess the company's operational status and decision-making processes.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on standard corporate matters and does not indicate any unusual risks or significant events.
Key Numbers
- 001-38319 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-8957988 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Quanterix Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- September 29, 2025 (date) — Date of earliest event reported
- October 2, 2025 (date) — Filing date
- 900 Middlesex Turnpike, Billerica, MA 01821 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Quanterix's security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Quanterix Corporation?
Quanterix Corporation is engaged in the business of manufacturing laboratory analytical instruments, as indicated by its SIC code [3826].
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on September 29, 2025.
What is Quanterix Corporation's principal executive office address?
Quanterix Corporation's principal executive office is located at 900 Middlesex Turnpike, Billerica, MA 01821.
What is the fiscal year end for Quanterix Corporation?
Quanterix Corporation's fiscal year ends on December 31.
Filing Stats: 815 words · 3 min read · ~3 pages · Grade level 13.7 · Accepted 2025-10-02 16:26:42
Key Financial Figures
- $0.001 — e on which registered: Common Stock, $0.001 par value per share QTRX The Nasdaq Glo
Filing Documents
- qtrx-20250929.htm (8-K) — 52KB
- qtrx-proposedcharteramendm.htm (EX-3.1) — 43KB
- restatedbylaws.htm (EX-3.2) — 136KB
- 0001503274-25-000097.txt ( ) — 383KB
- qtrx-20250929.xsd (EX-101.SCH) — 2KB
- qtrx-20250929_lab.xml (EX-101.LAB) — 21KB
- qtrx-20250929_pre.xml (EX-101.PRE) — 12KB
- qtrx-20250929_htm.xml (XML) — 3KB
07 Shareholder Director Nominations. Submission of Matters to a Vote of Security Holders
Item 5.07 Shareholder Director Nominations. Submission of Matters to a Vote of Security Holders. At the 2025 Annual Meeting of Stockholders of Quanterix Corporation (the "Company") held on September 29, 2025, as adjourned from September 23, 2025 (the "Annual Meeting"), the stockholders of the Company voted on and approved the following matters, which are described in detail in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on August 25, 2025 (File No. 001-38319) (the "Proxy Statement"): (1) to elect Myla Lai-Goldman, M.D., Masoud Toloue, Ph.D. and David R. Walt, Ph.D. as independent directors to each serve for a three-year term expiring at the Company's annual meeting of stockholders in 2028, and until their successors have been elected and qualified, or until their earlier death, resignation, retirement or removal ("Proposal 1"); (2) an advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the Proxy Statement ("Proposal 2"); (3) to ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 ("Proposal 3"); (4) to approve an amendment to the Company's Certificate of Incorporation (the "Charter") to declassify its Board of Directors ("Proposal 4"); (5) to approve an amendment to the Charter to eliminate the supermajority stockholder vote requirement for stockholders to amend certain provisions of the Charter ("Proposal 5"); and (6) to approve an amendment to the Charter to eliminate the supermajority stockholder vote requirement for stockholders to amend the Company's Bylaws ("Proposal 6"). The tabulation of votes with respect to the proposals at the Annual Meeting was as follows: Proposal 1 — Election of Directors: For Withheld Broker Non-Votes Myla Lai-Goldman, M.D. 35,731,623 163,772 4,293,146 Masoud Toloue, Ph.D. 32,552,678 3,342,717 4,293,146 David R. Walt, Ph.D. 29,705,101 6,
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 A mended and Restated Certificate of In corporation 3.2 R estated Bylaws 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 2, 2025 QUANTERIX CORPORATION By: /s/ Vandana Sriram Name: Vandana Sriram Title: Chief Financial Officer